The Studies
We are profoundly grateful to the over 46,000 people participating in our landmark COVID-19 vaccine clinical trial. Because of them, we are now able to enroll volunteers in new studies that will help us learn more about the vaccine for specific groups of people.

The COVID-19 Omicron Variant BA.4/BA.5 Targeted Vaccine Study
For previously vaccinated and boosted adolescents 12-17 years of age, and adults 56 years of age and older. Now enrolling.

The COVID-19 Vaccine Study For Immunocompromised Patients
For adults and children 2-17 Now enrolling.

The COVID-19 Vaccine Landmark Study
For individuals 12 years old and over. This study is ongoing but no longer enrolling new participants.

The COVID-19 Vaccine Maternal Study
For expectant mothers 18 years old and over. No longer enrolling.

The COVID-19 Vaccine Pediatric Study
For children 6 months to 11 years old. No longer enrolling.

THE COVID-19 Vaccine Study for the Omicron Variant
For unvaccinated and vaccinated 18-55 year olds. No longer enrolling.